PARS2 and malaria: Another example is febrifugine, a specific prolyl-tRNA synthetase (ProRS) inhibitor, which displayed high efficacy against both liver and asexual blood stages of the malaria parasite and was validated in the P. berghei mouse model of malaria [14].